Skip to main content
Erschienen in: Acta Neurologica Belgica 1/2021

15.09.2020 | Original article

Dementia with Lewy bodies in first-generation immigrants in a European memory clinic

verfasst von: Kurt Segers, Florence Benoit, Jean-Marie Meyts, Gérald Glibert, Sophie Levy, Murielle Surquin

Erschienen in: Acta Neurologica Belgica | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

We wanted to explore possible differences in disease presentation, frequency, and age of onset of dementia with Lewy bodies (DLB) between first-generation immigrants (FGI) and patients born in Belgium (PBIB). We conducted a retrospective study on all patients of our Memory Clinic between June 1, 2010 and January 31, 2020. A synucleinopathy was diagnosed in 150 of 2702 patients (5.5%): 91 received a diagnosis of DLB (3.4%). FGI were two times more likely to receive a diagnosis of DLB, due to a higher prevalence in North-Africans and Latin-Americans. Visual hallucinations were less frequent in North-Africans than in other immigrants. FGI were younger than PBIB and reported more often parasomnia. Our data suggest a higher risk for DLB in certain immigrant groups. Especially for North-African patients, a genetic factor can be suspected, namely mutations in Leucine-rich repeat kinase 2 (LRRK2). Memory clinics with a high rate of FGI may provide interesting data and insights into the prevalence of DLB, genetic and environmental differences.
Literatur
1.
Zurück zum Zitat Jellinger KA, Korczyn AD (2018) Are dementia with Lewy bodies and Parkinson's disease dementia the same disease? BMC Med 16:34CrossRef Jellinger KA, Korczyn AD (2018) Are dementia with Lewy bodies and Parkinson's disease dementia the same disease? BMC Med 16:34CrossRef
2.
Zurück zum Zitat Galvin JE, Balasubramaniam M. (2013) Lewy body dementia: the under-recognized but common FOE. In: Cerebrum: the Dana forum on brain science, p 13 Galvin JE, Balasubramaniam M. (2013) Lewy body dementia: the under-recognized but common FOE. In: Cerebrum: the Dana forum on brain science, p 13
3.
Zurück zum Zitat Segers K, Benoit F, Colson C, Kovac V, Nury D, Vanderaspoilden V (2013) Pioneers in migration, pioneering in dementia: first generation immigrants in a cosmopolitan memory clinic. Acta Neurol Belg 113:435–440CrossRef Segers K, Benoit F, Colson C, Kovac V, Nury D, Vanderaspoilden V (2013) Pioneers in migration, pioneering in dementia: first generation immigrants in a cosmopolitan memory clinic. Acta Neurol Belg 113:435–440CrossRef
4.
Zurück zum Zitat McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89:88–100CrossRef McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89:88–100CrossRef
5.
Zurück zum Zitat Yamada M, Komatsu J, Nakamura K, Sakai K, Samuraki-Yokohama M, Nakajima K, Yoshita M (2020) Diagnostic criteria for dementia with Lewy bodies: updates and future directions. J Mov Disord 13:1–10CrossRef Yamada M, Komatsu J, Nakamura K, Sakai K, Samuraki-Yokohama M, Nakajima K, Yoshita M (2020) Diagnostic criteria for dementia with Lewy bodies: updates and future directions. J Mov Disord 13:1–10CrossRef
6.
Zurück zum Zitat Dubois B, Feldmann HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G et al (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734–746CrossRef Dubois B, Feldmann HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G et al (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734–746CrossRef
7.
Zurück zum Zitat Custodio N, Wheelock A, Thumala D, Slachevsky A (2017) Dementia in Latin America: epidemiological evidence and implications for public policy. Front Aging Neurosci 13:221CrossRef Custodio N, Wheelock A, Thumala D, Slachevsky A (2017) Dementia in Latin America: epidemiological evidence and implications for public policy. Front Aging Neurosci 13:221CrossRef
8.
Zurück zum Zitat Benamer HT, de Silva R, Siddiqui KA, Grosset DG (2008) Parkinson's disease in Arabs: a systematic review. Mov Disord 23:1205–1210CrossRef Benamer HT, de Silva R, Siddiqui KA, Grosset DG (2008) Parkinson's disease in Arabs: a systematic review. Mov Disord 23:1205–1210CrossRef
9.
Zurück zum Zitat Ben-Joseph A, Marshal CR, Lees AJ, Noyce AJ (2020) Ethnic variation in the manifestation of Parkinson’s disease: a narrative review. J Park Dis 10:31–45 Ben-Joseph A, Marshal CR, Lees AJ, Noyce AJ (2020) Ethnic variation in the manifestation of Parkinson’s disease: a narrative review. J Park Dis 10:31–45
10.
Zurück zum Zitat Suemoto CK, Ferretti-Rebustini RE, Rodriguez RD, Leite RE, Soterio L, Brucki SM, Spera RR, Cippiciani TM, Farfel JM, Filho AC et al (2017) Neuropathological diagnoses and clinical correlates in older adults in Brazil. PLoS Med 14:e1002267CrossRef Suemoto CK, Ferretti-Rebustini RE, Rodriguez RD, Leite RE, Soterio L, Brucki SM, Spera RR, Cippiciani TM, Farfel JM, Filho AC et al (2017) Neuropathological diagnoses and clinical correlates in older adults in Brazil. PLoS Med 14:e1002267CrossRef
11.
Zurück zum Zitat Ogunniyi A, Daif AK, Al-Rajeh S, AbdulJabbar M, Al-Tahan AR, Al-Bunyan M, Shamina AR (1998) Dementia in Saudi Arabia: experience from a university hospital. Acta Neurol Scand 98:116–120CrossRef Ogunniyi A, Daif AK, Al-Rajeh S, AbdulJabbar M, Al-Tahan AR, Al-Bunyan M, Shamina AR (1998) Dementia in Saudi Arabia: experience from a university hospital. Acta Neurol Scand 98:116–120CrossRef
12.
Zurück zum Zitat Benamer HT, de Silva R (2010) LRRK2 G2019S in the North African population: a review. Eur Neurol 63:321–325CrossRef Benamer HT, de Silva R (2010) LRRK2 G2019S in the North African population: a review. Eur Neurol 63:321–325CrossRef
13.
Zurück zum Zitat Zhu X, Babar A, Siedlak SL, Yang Q, Ito G, Iwatsubo T, Smith MA, Perry G, Chen SG (2006) LRRK2 in Parkinson's disease and dementia with Lewy bodies. Mol Neurodegener 1:17CrossRef Zhu X, Babar A, Siedlak SL, Yang Q, Ito G, Iwatsubo T, Smith MA, Perry G, Chen SG (2006) LRRK2 in Parkinson's disease and dementia with Lewy bodies. Mol Neurodegener 1:17CrossRef
14.
Zurück zum Zitat Ben Romdhan S, Farhat N, Nasri A, Lesage S, Hdiji O, Ben Djebara M, Landoulsi Z, Stevanin G, Brice A, Damak M et al (2018) LRRK2 G2019S Parkinson's disease with more benign phenotype than idiopathic. Acta Neurol Scand 138:425–431CrossRef Ben Romdhan S, Farhat N, Nasri A, Lesage S, Hdiji O, Ben Djebara M, Landoulsi Z, Stevanin G, Brice A, Damak M et al (2018) LRRK2 G2019S Parkinson's disease with more benign phenotype than idiopathic. Acta Neurol Scand 138:425–431CrossRef
15.
Zurück zum Zitat Brucki SM (2010) Illiteracy and dementia. Dementia Neuropsy 4:153–157CrossRef Brucki SM (2010) Illiteracy and dementia. Dementia Neuropsy 4:153–157CrossRef
16.
Zurück zum Zitat Ardila A, Bertolucci PH, Braga LW (2010) Illiteracy: the neuropsychology of cognition without reading. Arch Clin Neuropsy 25:689–712CrossRef Ardila A, Bertolucci PH, Braga LW (2010) Illiteracy: the neuropsychology of cognition without reading. Arch Clin Neuropsy 25:689–712CrossRef
17.
Zurück zum Zitat Pont-Sunyer C, Iranzo A, Gaig C, Fernández-Arcos A, Vilas D, Valldeoriola F, Compta Y, Fernández-Santiago R, Fernández M, Bayés A et al (2015) Sleep disorders in Parkinsonian and nonparkinsonian LRRK2 mutation carriers. PLoS ONE 15:10 Pont-Sunyer C, Iranzo A, Gaig C, Fernández-Arcos A, Vilas D, Valldeoriola F, Compta Y, Fernández-Santiago R, Fernández M, Bayés A et al (2015) Sleep disorders in Parkinsonian and nonparkinsonian LRRK2 mutation carriers. PLoS ONE 15:10
18.
Zurück zum Zitat Saunders-Pullman R, Alcalay RN, Mirelman A, Wang C, San Luciano M, Ortega RA, Glickman A, Raymond D, Mejia-Santana H, Doan N et al (2015) REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers. Mov Disord 30:1834–1839CrossRef Saunders-Pullman R, Alcalay RN, Mirelman A, Wang C, San Luciano M, Ortega RA, Glickman A, Raymond D, Mejia-Santana H, Doan N et al (2015) REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers. Mov Disord 30:1834–1839CrossRef
19.
Zurück zum Zitat Boot BP, Orr CF, Ahlskog JE, Ferman TJ, Roberts R, Pankratz VS, Dickson DW, Parisi J, Aakre JA, Geda YE et al (2013) Risk factors for dementia with Lewy bodies: a case-control study. Neurology 81:833–840CrossRef Boot BP, Orr CF, Ahlskog JE, Ferman TJ, Roberts R, Pankratz VS, Dickson DW, Parisi J, Aakre JA, Geda YE et al (2013) Risk factors for dementia with Lewy bodies: a case-control study. Neurology 81:833–840CrossRef
20.
Zurück zum Zitat NCD Risk Factor Collaboration (NCD-RisC) (2016) Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387:1513–1530CrossRef NCD Risk Factor Collaboration (NCD-RisC) (2016) Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet 387:1513–1530CrossRef
21.
Zurück zum Zitat Frigerio R, Fujishiro H, Maraganore DM, Klos KJ, DelleDonne A, Heckman MG, Crook JE, Josephs KA, Parisi JE, Boeve BF, Dickson DW, Ahlskog JE et al (2009) Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease. Arch Neurol 66:1114–1119CrossRef Frigerio R, Fujishiro H, Maraganore DM, Klos KJ, DelleDonne A, Heckman MG, Crook JE, Josephs KA, Parisi JE, Boeve BF, Dickson DW, Ahlskog JE et al (2009) Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease. Arch Neurol 66:1114–1119CrossRef
22.
Zurück zum Zitat Boulos C, Yaghi N, El Hayeck R (2019) Nutritional risk factors, microbiota and Parkinson’s disease: what is the current evidence? Nutrients 11:1896CrossRef Boulos C, Yaghi N, El Hayeck R (2019) Nutritional risk factors, microbiota and Parkinson’s disease: what is the current evidence? Nutrients 11:1896CrossRef
23.
Zurück zum Zitat Yan R, Zhang J, Park HJ, Park ES, Oh S, Zheng H, Junn E, Voronkov M, Stock JB, Mouradian MM (2018) Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson’s disease and DLB. PNAS USA 115:E12053–E12062CrossRef Yan R, Zhang J, Park HJ, Park ES, Oh S, Zheng H, Junn E, Voronkov M, Stock JB, Mouradian MM (2018) Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson’s disease and DLB. PNAS USA 115:E12053–E12062CrossRef
24.
Zurück zum Zitat Mukadam N, Cooper C, Basi B, Livingston G (2011) Why do ethnic elders present later to UK dementia services? A qualitative study”. Int Psychogeriatr 23:1070–1077CrossRef Mukadam N, Cooper C, Basi B, Livingston G (2011) Why do ethnic elders present later to UK dementia services? A qualitative study”. Int Psychogeriatr 23:1070–1077CrossRef
Metadaten
Titel
Dementia with Lewy bodies in first-generation immigrants in a European memory clinic
verfasst von
Kurt Segers
Florence Benoit
Jean-Marie Meyts
Gérald Glibert
Sophie Levy
Murielle Surquin
Publikationsdatum
15.09.2020
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 1/2021
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-020-01492-2

Weitere Artikel der Ausgabe 1/2021

Acta Neurologica Belgica 1/2021 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.